Patent US1848757A successfully refreshed from Google Patents.
Patent US4834753A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5037643A Expired / Lapsed US ⏱️ 0.0 years remaining

Cosmetic composition

Assignee: Chesebrough Ponds USA Inc
•
Filing: 1989-03-22
•
Granted: 1991-08-06
•
Expires: 2009-03-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition suitable for topical application to mammalian skin or hair comprises: (a) a growth factor chosen from: (i) transforming growth factor alpha (TGF-α), (ii) transforming growth factor beta (TGF-β), (iii) insulin-like growth factor-1 (IGF-1), (iv) fragments thereof of one or more of said growth factors, and (v) mixtures thereof of said growth factors or fragments of said growth factors; and (b) a cosmetically acceptable vehicle for the growth factor or fragments thereof; the total amount of growth factor being sufficient to increase hair growth in the rate, when the composition is applies topically thereto over a period of no more than 3 months, by at least 10% more than that obtainable using a control composition from which the said growth factor has been omitted, in accordance with the Rat Hair Growth Test.

Inventors

  • 👤 Martin R. Green

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 23:47
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/64; A61P; A61P17/00; A61P43/00; A61Q; A61Q7/00

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 133 words
A composition suitable for topical application to mammalian skin or hair which comprises: (a) a growth factor chosen from: (i) transforming growth factor alpha (TGF-α), (ii) transforming growth factor beta (TGF-β), (iii)insulin-like growth factor-1 (IGF-1), (iv) fragments thereof of one or more of said growth factors, and (v) mixtures thereof of said growth factors or fragments of said growth factors; and (b) a cosmetically acceptable vehicle for the growth factor or fragments thereof; the total amount of growth factor being sufficient to increase hair growth in the rat, when the composition is applied topically thereto over a period of no more than 3 months, by at least 10% more than that obtainable using a control composition from which the said growth factor has been omitted, in accordance with the Rat Hair Growth Test.
Claim 2
Dependent Claim 133 words
A composition suitable for topical application to mammalian skin or hair which comprises: (a) a growth factor chosen from: (i) transforming growth factor alpha (TGF-α), (ii) transforming growth factor beta (TGF-β), (iii)insulin-like growth factor-1 (IGF-1), (iv) fragments thereof of one or more of said growth factors, and (v) mixtures thereof of said growth factors or fragments of said growth factors; and (b) a cosmetically acceptable vehicle for the growth factor or fragments thereof; the total amount of growth factor being sufficient to increase hair growth in the rat, when the composition is applied topically thereto over a period of no more than 3 months, by at least 10% more than that obtainable using a control composition from which the said growth factor has been omitted, in accordance with the Rat Hair Growth Test.
Claim 3
Dependent Claim 15 words
The composition of claim 1, wherein the growth factor forms from 0.0002 to 10 mg/ml.
Claim 4
Dependent Claim 14 words
The composition of claim 2, which comprises from 0.0005 to 30 μg/ml of TGF-α.
Claim 5
Dependent Claim 14 words
The composition of claim 1, which comprises from 0.0002 to 20 μg/ml of TGF-β.
Claim 6
Dependent Claim 14 words
The composition of claim 1, which comprises from 0.0002 to 70 μg/ml of IGF-1.
Claim 7
Dependent Claim 43 words
The composition of claim 1, further comprising a protein stabilizing agent present in an effective amount for enhancing the activity of said growth factor which is selected from the group consisting of: glycerol ethylenediaminetetraacetic acid cysteine α 2 -macroglobulin serum and mixtures thereof.
Claim 8
Dependent Claim 35 words
The composition of claim 1, further comprising means for enhancing the activity of said growth factor which is an iontophoretic device comprising a pad of absorbent material impregnated with a solution containing said growth factors.
Claim 9
Dependent Claim 35 words
A method for converting vellus hair to growth as terminal hair, which comprises the step of applying to the scalp in the region of vellus hair an effective amount of the composition of claim 1.
Claim 10
Dependent Claim 34 words
A method for increasing the rate of terminal hair growth, which comprises the step of applying to the scalp in the region of terminal hair an effective amount of the composition of claim 1.
Claim 11
Dependent Claim 653 words
The composition of claim 1 additionally comprising a hair growth stimulant in an effective amount for enhancing the activity of said growth factor selected from the group consisting of: (i) --1,4 esterified disaccharides having the structure (1): ##STR17## where Z represents a functional nitrogen group, such as an azide or a group having the structure --NHB, in which B represents --H or a functional group such as acetyl or sulphate as a salt with an organic or mineral cation; M represents --H or SO 3 M 1 , where M 1 is an organic or metallic cation or an acetyl group; R represents a C 1 to C 4 alkyl radical or an aryl radical; A represents a functional group such as an acid or --COOR 1 , where R 1 represents --H or a C 1 to C 4 alkyl radical or a metal; (ii) esterified oligosaccharieds including at least one esterified disaccharide unit consisting of uronic acid residue having the structure (2) and a hexosamine residue having the structure (3); ##STR18## and a hexosamine residue having the structure (3): ##STR19## where R' is C 3 to C 10 alkyl or ##STR20## R" is --H, C 1 to C 4 alkyl, --CO(CH 2 ) m CH 3 ,--SO 3 M', R'" is --H, --CO(CH 2 ) m CH 3 , or --SO 3 M', M' is --H, or a metallic or organic cation n is 0 or an integer of from 1 to 7, and m is 0 or the integer 1 or 2; the groups designated R" being the same or different, one R" group from each pyranose ring structure being linked by a glycosidic linkage having the configuration α-1,3, α-1,4, β-1,3 or β-1,4; and the --COOR', --CH 2 OR" and --OR" groups being of either configuration with respect to the pyranose rings; (iii) 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine; (iv) 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine glucoronide; (v) 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine sulphates; (vi) 1,10-phenanthroline; (vii) glycosaminoglycanase inhibitors having the structure (5) and (6): ##STR21## where A is --OG or --NHCOCH 3 G is --H, --SO 3 M", C 2 to C 4 acyl G' is --H or --OG M" is --H or a metal cation (viii) glycosaminoglycanase chain cellular uptake inhibitors having the structure (7): ##STR22## where G is --H, --SO 3 M", C 2 to C 4 acyl; D is --H or C 2 to C 8 alkyl M" is --H or a metal cation; wherein the functional groups can be in either configuration with respect to the backbone of the above molecule; (ix) glycosidase inhibitors having the structure (8): ##STR23## where A 1 and A 6 are --H, --CH 3 , ##STR24## --CH 2 OT ##STR25## A 1 and A 6 being the same or different, and at least one of which being the group; ##STR26## in a lactum ring; and where Q is --OT', --NHT' or a lactam linkage to A 1 or A 6 ; the Q groups being the same or different, and at least one of which is involved in a lactam linkage; and where T is the same or different and is chosen from --H, --C p H 2p+1 or a metal ion, T' is --H or --COC p H 2p+1 , and p is an integer of from 1 to 22; provided that: where any of the Q groups is --OT' or --NHT', then that group or groups can be of either stereochemical configuration with respect to the plane of the ring; (x) chemical activators of protein kinase C having the structure (9): ##STR27## where X is the same or different and is represented by the grouping: ##STR28## where x is 0 or an integer of from 1 to 28, and y is 0 or an integer of from 1 to 5; the OX groups being of either stereochemical configuration with respect to the carbon backbone of the glycerol molecule, the double bonds being of either cis or trans configuration; and (xi) mixtures thereof.
Claim 12
Dependent Claim 12 words
The composition of claim 10, wherein the hair growth stimulant is 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine.
Claim 13
Dependent Claim 19 words
The composition of claim 10, wherein the glycosaminoglycanase inhibitor is an aldonolactone or an esterified aldonolactone having structure (5).
Claim 14
Dependent Claim 19 words
The composition of claim 10, wherein the glycosaminoglycanase inhibitor is a monosacchride or an esterified mnosaccharide having structure (6).
Claim 15
Dependent Claim 16 words
The composition of claim 10, wherein the glycosidase inhibitor is a lactam having the structure (8).
Claim 16
Dependent Claim 20 words
The composition of claim 10, wherein the chemical activator of protein kinase C is a diacylglycerol having the structure (9).
Claim 17
Dependent Claim 178 words
The composition of claim 1, further comprising a means for enhancing the activity of said growth factor with a penetration enhancer which is selected from the group consisting of: 1-dodecylazacyclopheptan-2-one, dibutyl sebacate, 2-hydroxyoctanoic acid, esters of pyroglutamic acid having the structure (10) ##STR29## where Z is C 1 to C 30 alkyl, or ##STR30## and where Z' and Z" are the same or different and are each represented by H or the grouping (11): [(CH.sub.3).sub.u, (CH.sub.2 OH).sub.v, (CH.sub.2).sub.w, (CH.sub.3 CH.sub.2).sub.s, (CH═CH).sub.z ]-- (11) where u is zero or 1 v is zero, or the integer of from 1 to 2, w is zero, or an integer of from 1 to 21 s is zero, or an integer of from 1 to 4, y is zero, or the integer 1 or 2, z is zero, or an integer of from 1 to 22, and u+v+w+x+y+z is an integer of from 1 to 22; provided that when the subgrouping (CH═CH) is present, then the total number of carbon atoms in said grouping is from 10 to 22, and mixtures thereof.
Claim 18
Dependent Claim 42 words
The composition of claim 1, further comprising a penetration enhancer present in an effective amount for enhancing the activity of said growth factor which is a surface active agent selected from the group consisting of anionic, cationic, amphoteric and nonionic wetting agents.
Claim 19
Dependent Claim 54 words
The composition of claim 1, further comprising an effective amount for enhancing the activity of said growth factor of a cationic polymer selected from the group consisting of: Guar Hydroxypropyltrimonium chloride Quaternium-19 Quaternium-23 Quaternium-40 Quaternium-57 Poly(dipropyldiallylammonium chloride) Poly(methyl-β-propaniodiallylammonium chloride) Poly(diallylpiperidinium chloride) Poly(vinyl pyridinium chloride) Quaternized poly (vinyl alcohol) Quaternized poly (dimethylaminoethylmethacrylate); and mixtures thereof.

References Cited (Backward Citations)

US4139619A Cited
EP0035919A2 Cited
JPS59186911A Cited
WO1985004577A1 Cited
DE3431266A1 Cited
US4832946A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-08-05 1995-02-04 1995-08-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-08-05 1999-02-04 1999-08-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-08-05 2003-02-04 2003-08-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag